TKT and cancer: This contrasts the existing trend for GCV use in cancer therapeutics, where GCV is not used to control oncolytic viral replication, but rather to enhance the therapeutic efficacy by inducing targeted cancer cytotoxicity; for example, the incorporation of wild type HSV-tk gene into adenovirus backbone for oncolytic adenovirus suicide gene therapy [23,24].